![(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide, >=97% (HPLC), powder](/images/1000x1000/WebCat-0007000a000700ba.jpg "(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide, >=97% (HPLC), powder")
(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide, >=97% (HPLC), powder
Amino Acid Sequence
Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2
Application
(Tyr[SO3H]27)Cholecystokinin fragment 26-33 amide has been used to test its effects:to study its effects on ?5i/LMP7 immunoproteasome subunit in pancreatitison gastric emptying,food intake and c-Fos immunoreactivity in small litter (SL) and normal litter (NL) ratson the intestine and gallbladder motility in fish Ballan Wrasse
Biochem/physiol Actions
(Tyr[SO3H]27)Cholecystokinin fragment 26-33 amide activates the cholecystokinin type B receptor and may mediate the blockage of opioid analgesia. It elicits anti-inflammatory effects. It mediates the inhibition on cytokine release, lymphocytes, and macrophages.
Neurotransmitter; predominant form of CCK in CNS and gastrointestinal tract; may play a role in satiety.
General description
(Tyr[SO3H]27)Cholecystokinin fragment 26-33 amide is a sulfated cholecystokinin(CCK) octapeptide derived from the proCCK. It is present in plasma and endocrine cells.
Other Notes
C-Terminal octapeptide of cholecystokinin
No detailed specifications are available for this product.
There are no downloads for this product.
